Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-01-04

AUTHORS

Akira Hachiya, Norimoto Kobayashi, Satoshi Matsuzaki, Yusuke Takeuchi, Yohei Akazawa, Tomonari Shigemura, Noriko Motoki, Junya Masumoto, Kazunaga Agematsu

ABSTRACT

Infliximab (IFX) is effective for treatment of refractory Kawasaki disease (KD). However, the precise mechanisms and biomarkers for IFX efficacy are unknown. We tried to evaluate the effect and response to IFX therapy by measuring serum cytokine levels. Twenty-nine children with KD who had been resistant to two courses of high-dose intravenous immunoglobulin were enrolled and treated with IFX. Plasma samples were analyzed for cytokines before and after IFX administration. Serum levels of interleukin-6, granulocyte colony-stimulating factor (G-CSF), interferon-gamma-induced monokine, interferon-gamma inducible protein 10 (IP-10), monocyte chemotactic protein 1, and soluble tumor necrosis factor-alpha receptor (sTNFR) 1 and 2 were significantly elevated before IFX treatment, but promptly decreased after the administration. The pre-treatment G-CSF and sTNFR1 levels in non-responders to IFX were significantly higher than in responders, who were defined as patients who defervesce (< 37.5 °C). After IFX administration, elevated cytokines declined to normal ranges in responders, but in non-responsive group, G-CSF and sTNFR1 remained elevated without failing to normal levels. IFX treatment significantly reduced the levels of serum cytokines, chemokines, and sTNFRs in refractory KD. G-CSF and sTNFR1 may be indicators predictive of poor response to IFX. More... »

PAGES

1937-1943

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10067-017-3952-7

DOI

http://dx.doi.org/10.1007/s10067-017-3952-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1100160386

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29302828


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antirheumatic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytokines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulins, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infliximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mucocutaneous Lymph Node Syndrome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263518.b", 
          "name": [
            "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hachiya", 
        "givenName": "Akira", 
        "id": "sg:person.0615251217.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615251217.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263518.b", 
          "name": [
            "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobayashi", 
        "givenName": "Norimoto", 
        "id": "sg:person.01173340764.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173340764.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263518.b", 
          "name": [
            "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsuzaki", 
        "givenName": "Satoshi", 
        "id": "sg:person.0731477617.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731477617.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263518.b", 
          "name": [
            "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takeuchi", 
        "givenName": "Yusuke", 
        "id": "sg:person.0727351117.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727351117.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263518.b", 
          "name": [
            "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Akazawa", 
        "givenName": "Yohei", 
        "id": "sg:person.01246627523.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246627523.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263518.b", 
          "name": [
            "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shigemura", 
        "givenName": "Tomonari", 
        "id": "sg:person.01135142346.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135142346.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263518.b", 
          "name": [
            "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Motoki", 
        "givenName": "Noriko", 
        "id": "sg:person.01143663550.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143663550.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Ehime University Proteo-Science Center and Graduate School of Medicine, Toon, Ehime, Japan", 
          "id": "http://www.grid.ac/institutes/grid.255464.4", 
          "name": [
            "Department of Pathology, Ehime University Proteo-Science Center and Graduate School of Medicine, Toon, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masumoto", 
        "givenName": "Junya", 
        "id": "sg:person.0765147410.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765147410.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Infection and Host Defense, Graduate School of Medicine, Shinshu University, Asahi 3-1-1, 390-8621, Matsumoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263518.b", 
          "name": [
            "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan", 
            "Department of Infection and Host Defense, Graduate School of Medicine, Shinshu University, Asahi 3-1-1, 390-8621, Matsumoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Agematsu", 
        "givenName": "Kazunaga", 
        "id": "sg:person.0702402436.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702402436.32"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12887-015-0424-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046549422", 
          "https://doi.org/10.1186/s12887-015-0424-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1203/pdr.0b013e31819ed68d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046155604", 
          "https://doi.org/10.1203/pdr.0b013e31819ed68d"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1546-0096-9-15", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005348325", 
          "https://doi.org/10.1186/1546-0096-9-15"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1203/01.pdr.0000352115.41382.65", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052146328", 
          "https://doi.org/10.1203/01.pdr.0000352115.41382.65"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10067-016-3370-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008750519", 
          "https://doi.org/10.1007/s10067-016-3370-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-01-04", 
    "datePublishedReg": "2018-01-04", 
    "description": "Infliximab (IFX) is effective for treatment of refractory Kawasaki disease (KD). However, the precise mechanisms and biomarkers for IFX efficacy are unknown. We tried to evaluate the effect and response to IFX therapy by measuring serum cytokine levels. Twenty-nine children with KD who had been resistant to two courses of high-dose intravenous immunoglobulin were enrolled and treated with IFX. Plasma samples were analyzed for cytokines before and after IFX administration. Serum levels of interleukin-6, granulocyte colony-stimulating factor (G-CSF), interferon-gamma-induced monokine, interferon-gamma inducible protein 10 (IP-10), monocyte chemotactic protein 1, and soluble tumor necrosis factor-alpha receptor (sTNFR) 1 and 2 were significantly elevated before IFX treatment, but promptly decreased after the administration. The pre-treatment G-CSF and sTNFR1 levels in non-responders to IFX were significantly higher than in responders, who were defined as patients who defervesce (<\u200937.5\u00a0\u00b0C). After IFX administration, elevated cytokines declined to normal ranges in responders, but in non-responsive group, G-CSF and sTNFR1 remained elevated without failing to normal levels. IFX treatment significantly reduced the levels of serum cytokines, chemokines, and sTNFRs in refractory KD. G-CSF and sTNFR1 may be indicators predictive of poor response to IFX.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10067-017-3952-7", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6822580", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6957037", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.9338762", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1093299", 
        "issn": [
          "0770-3198", 
          "1434-9949"
        ], 
        "name": "Clinical Rheumatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "keywords": [
      "refractory Kawasaki disease", 
      "Kawasaki disease", 
      "IFX administration", 
      "IFX treatment", 
      "serum levels", 
      "soluble tumor necrosis factor alpha receptor 1", 
      "interferon-gamma inducible protein-10", 
      "high-dose intravenous immunoglobulin", 
      "tumor necrosis factor alpha receptor 1", 
      "Kawasaki disease patients", 
      "serum cytokine levels", 
      "granulocyte colony-stimulating factor", 
      "inducible protein-10", 
      "chemotactic protein-1", 
      "biomarker serum levels", 
      "non-responsive group", 
      "colony-stimulating factor", 
      "IFX therapy", 
      "intravenous immunoglobulin", 
      "elevated cytokines", 
      "serum cytokines", 
      "cytokine levels", 
      "disease patients", 
      "interleukin-6", 
      "poor response", 
      "infliximab", 
      "IFX efficacy", 
      "normal range", 
      "protein 10", 
      "receptor 1", 
      "normal levels", 
      "cytokines", 
      "protein 1", 
      "precise mechanism", 
      "plasma samples", 
      "administration", 
      "CSF", 
      "sTNFR1", 
      "patients", 
      "treatment", 
      "responders", 
      "sTNFRs", 
      "IVIG", 
      "levels", 
      "chemokines", 
      "monokine", 
      "therapy", 
      "disease", 
      "immunoglobulin", 
      "biomarkers", 
      "response", 
      "efficacy", 
      "children", 
      "group", 
      "course", 
      "factors", 
      "effect", 
      "mechanism", 
      "indicators", 
      "samples", 
      "analysis", 
      "range", 
      "necrosis factor-alpha receptor (sTNFR) 1", 
      "factor-alpha receptor (sTNFR) 1", 
      "refractory Kawasaki disease patients"
    ], 
    "name": "Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients", 
    "pagination": "1937-1943", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1100160386"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10067-017-3952-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29302828"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10067-017-3952-7", 
      "https://app.dimensions.ai/details/publication/pub.1100160386"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_785.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10067-017-3952-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10067-017-3952-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10067-017-3952-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10067-017-3952-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10067-017-3952-7'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      22 PREDICATES      109 URIs      96 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10067-017-3952-7 schema:about N405a3658d32a43e0af86c99bf528b40a
2 N5690ed51a5704d3aacfc4c48c430187b
3 N6787fae4ab2940afa67a39c6da13d249
4 N71f00bcd643b40f99fb09a038bb98404
5 N794cfff7d0734df0b9149f3bf9b7dac9
6 N7efac1b04bc1417db46834af9a3de147
7 N83e68a64df3545ada2371a1acfc6688c
8 N8712929782f24d1f838c9a191405902c
9 N8c0c5bb515e2400899515dc66c065252
10 N9f9b6eae20a04da580d13b0a2aa3ca17
11 Naed5ed2f365344da984e8c56898797bb
12 Nc96fe1c73f7041778f08468fb5f74dc7
13 Nd539156a8e544c4197ace2072c2e631d
14 anzsrc-for:11
15 anzsrc-for:1107
16 schema:author N1161f0b0421941d6a12dacc7b9bc7a05
17 schema:citation sg:pub.10.1007/s10067-016-3370-2
18 sg:pub.10.1186/1546-0096-9-15
19 sg:pub.10.1186/s12887-015-0424-6
20 sg:pub.10.1203/01.pdr.0000352115.41382.65
21 sg:pub.10.1203/pdr.0b013e31819ed68d
22 schema:datePublished 2018-01-04
23 schema:datePublishedReg 2018-01-04
24 schema:description Infliximab (IFX) is effective for treatment of refractory Kawasaki disease (KD). However, the precise mechanisms and biomarkers for IFX efficacy are unknown. We tried to evaluate the effect and response to IFX therapy by measuring serum cytokine levels. Twenty-nine children with KD who had been resistant to two courses of high-dose intravenous immunoglobulin were enrolled and treated with IFX. Plasma samples were analyzed for cytokines before and after IFX administration. Serum levels of interleukin-6, granulocyte colony-stimulating factor (G-CSF), interferon-gamma-induced monokine, interferon-gamma inducible protein 10 (IP-10), monocyte chemotactic protein 1, and soluble tumor necrosis factor-alpha receptor (sTNFR) 1 and 2 were significantly elevated before IFX treatment, but promptly decreased after the administration. The pre-treatment G-CSF and sTNFR1 levels in non-responders to IFX were significantly higher than in responders, who were defined as patients who defervesce (< 37.5 °C). After IFX administration, elevated cytokines declined to normal ranges in responders, but in non-responsive group, G-CSF and sTNFR1 remained elevated without failing to normal levels. IFX treatment significantly reduced the levels of serum cytokines, chemokines, and sTNFRs in refractory KD. G-CSF and sTNFR1 may be indicators predictive of poor response to IFX.
25 schema:genre article
26 schema:inLanguage en
27 schema:isAccessibleForFree true
28 schema:isPartOf N3a08e5ba7e1341538c7d8590a770ed69
29 Nea6c7bb33e0e4a2cbe5a7848ac203f73
30 sg:journal.1093299
31 schema:keywords CSF
32 IFX administration
33 IFX efficacy
34 IFX therapy
35 IFX treatment
36 IVIG
37 Kawasaki disease
38 Kawasaki disease patients
39 administration
40 analysis
41 biomarker serum levels
42 biomarkers
43 chemokines
44 chemotactic protein-1
45 children
46 colony-stimulating factor
47 course
48 cytokine levels
49 cytokines
50 disease
51 disease patients
52 effect
53 efficacy
54 elevated cytokines
55 factor-alpha receptor (sTNFR) 1
56 factors
57 granulocyte colony-stimulating factor
58 group
59 high-dose intravenous immunoglobulin
60 immunoglobulin
61 indicators
62 inducible protein-10
63 infliximab
64 interferon-gamma inducible protein-10
65 interleukin-6
66 intravenous immunoglobulin
67 levels
68 mechanism
69 monokine
70 necrosis factor-alpha receptor (sTNFR) 1
71 non-responsive group
72 normal levels
73 normal range
74 patients
75 plasma samples
76 poor response
77 precise mechanism
78 protein 1
79 protein 10
80 range
81 receptor 1
82 refractory Kawasaki disease
83 refractory Kawasaki disease patients
84 responders
85 response
86 sTNFR1
87 sTNFRs
88 samples
89 serum cytokine levels
90 serum cytokines
91 serum levels
92 soluble tumor necrosis factor alpha receptor 1
93 therapy
94 treatment
95 tumor necrosis factor alpha receptor 1
96 schema:name Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients
97 schema:pagination 1937-1943
98 schema:productId N7bd1f48a00b94c278acfa77e322769cf
99 N7de0142cc6bb43a1a9d0ab5ed727ac28
100 Nc5f9d0cc598949acb38d8737076f0983
101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100160386
102 https://doi.org/10.1007/s10067-017-3952-7
103 schema:sdDatePublished 2022-01-01T18:48
104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
105 schema:sdPublisher Na7574c8480804dcc8ecd1c9296b3131e
106 schema:url https://doi.org/10.1007/s10067-017-3952-7
107 sgo:license sg:explorer/license/
108 sgo:sdDataset articles
109 rdf:type schema:ScholarlyArticle
110 N1161f0b0421941d6a12dacc7b9bc7a05 rdf:first sg:person.0615251217.20
111 rdf:rest Nac4c5a85dfdf4203aa944c4d86d75d83
112 N3a08e5ba7e1341538c7d8590a770ed69 schema:volumeNumber 37
113 rdf:type schema:PublicationVolume
114 N405a3658d32a43e0af86c99bf528b40a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Cytokines
116 rdf:type schema:DefinedTerm
117 N5690ed51a5704d3aacfc4c48c430187b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N6787fae4ab2940afa67a39c6da13d249 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Antirheumatic Agents
122 rdf:type schema:DefinedTerm
123 N7077164978ec4f3eb9d51e72ff112fad rdf:first sg:person.0765147410.51
124 rdf:rest Ne4f485b2afca41a1b6bf890937a147ce
125 N71f00bcd643b40f99fb09a038bb98404 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Japan
127 rdf:type schema:DefinedTerm
128 N794cfff7d0734df0b9149f3bf9b7dac9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Child, Preschool
130 rdf:type schema:DefinedTerm
131 N7bd1f48a00b94c278acfa77e322769cf schema:name pubmed_id
132 schema:value 29302828
133 rdf:type schema:PropertyValue
134 N7de0142cc6bb43a1a9d0ab5ed727ac28 schema:name dimensions_id
135 schema:value pub.1100160386
136 rdf:type schema:PropertyValue
137 N7efac1b04bc1417db46834af9a3de147 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Infant
139 rdf:type schema:DefinedTerm
140 N83e68a64df3545ada2371a1acfc6688c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Biomarkers
142 rdf:type schema:DefinedTerm
143 N8712929782f24d1f838c9a191405902c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Child
145 rdf:type schema:DefinedTerm
146 N8c0c5bb515e2400899515dc66c065252 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Female
148 rdf:type schema:DefinedTerm
149 N9a5958e23f3c4131afd6a2841969fc2f rdf:first sg:person.0731477617.01
150 rdf:rest Nece78d2052d04e25bb1e80be47910ead
151 N9f44727241894295adb482e730ddc699 rdf:first sg:person.01135142346.82
152 rdf:rest Nf0c489fbbd224d8987f6b9187124e6a5
153 N9f9b6eae20a04da580d13b0a2aa3ca17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Male
155 rdf:type schema:DefinedTerm
156 Na7574c8480804dcc8ecd1c9296b3131e schema:name Springer Nature - SN SciGraph project
157 rdf:type schema:Organization
158 Nac4c5a85dfdf4203aa944c4d86d75d83 rdf:first sg:person.01173340764.15
159 rdf:rest N9a5958e23f3c4131afd6a2841969fc2f
160 Naed5ed2f365344da984e8c56898797bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Infliximab
162 rdf:type schema:DefinedTerm
163 Nc39e34477d65402d9ff59af5ab4ce0bb rdf:first sg:person.01246627523.65
164 rdf:rest N9f44727241894295adb482e730ddc699
165 Nc5f9d0cc598949acb38d8737076f0983 schema:name doi
166 schema:value 10.1007/s10067-017-3952-7
167 rdf:type schema:PropertyValue
168 Nc96fe1c73f7041778f08468fb5f74dc7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Immunoglobulins, Intravenous
170 rdf:type schema:DefinedTerm
171 Nd539156a8e544c4197ace2072c2e631d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Mucocutaneous Lymph Node Syndrome
173 rdf:type schema:DefinedTerm
174 Ne4f485b2afca41a1b6bf890937a147ce rdf:first sg:person.0702402436.32
175 rdf:rest rdf:nil
176 Nea6c7bb33e0e4a2cbe5a7848ac203f73 schema:issueNumber 7
177 rdf:type schema:PublicationIssue
178 Nece78d2052d04e25bb1e80be47910ead rdf:first sg:person.0727351117.01
179 rdf:rest Nc39e34477d65402d9ff59af5ab4ce0bb
180 Nf0c489fbbd224d8987f6b9187124e6a5 rdf:first sg:person.01143663550.35
181 rdf:rest N7077164978ec4f3eb9d51e72ff112fad
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
186 schema:name Immunology
187 rdf:type schema:DefinedTerm
188 sg:grant.6822580 http://pending.schema.org/fundedItem sg:pub.10.1007/s10067-017-3952-7
189 rdf:type schema:MonetaryGrant
190 sg:grant.6957037 http://pending.schema.org/fundedItem sg:pub.10.1007/s10067-017-3952-7
191 rdf:type schema:MonetaryGrant
192 sg:grant.9338762 http://pending.schema.org/fundedItem sg:pub.10.1007/s10067-017-3952-7
193 rdf:type schema:MonetaryGrant
194 sg:journal.1093299 schema:issn 0770-3198
195 1434-9949
196 schema:name Clinical Rheumatology
197 schema:publisher Springer Nature
198 rdf:type schema:Periodical
199 sg:person.01135142346.82 schema:affiliation grid-institutes:grid.263518.b
200 schema:familyName Shigemura
201 schema:givenName Tomonari
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135142346.82
203 rdf:type schema:Person
204 sg:person.01143663550.35 schema:affiliation grid-institutes:grid.263518.b
205 schema:familyName Motoki
206 schema:givenName Noriko
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143663550.35
208 rdf:type schema:Person
209 sg:person.01173340764.15 schema:affiliation grid-institutes:grid.263518.b
210 schema:familyName Kobayashi
211 schema:givenName Norimoto
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173340764.15
213 rdf:type schema:Person
214 sg:person.01246627523.65 schema:affiliation grid-institutes:grid.263518.b
215 schema:familyName Akazawa
216 schema:givenName Yohei
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246627523.65
218 rdf:type schema:Person
219 sg:person.0615251217.20 schema:affiliation grid-institutes:grid.263518.b
220 schema:familyName Hachiya
221 schema:givenName Akira
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615251217.20
223 rdf:type schema:Person
224 sg:person.0702402436.32 schema:affiliation grid-institutes:grid.263518.b
225 schema:familyName Agematsu
226 schema:givenName Kazunaga
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702402436.32
228 rdf:type schema:Person
229 sg:person.0727351117.01 schema:affiliation grid-institutes:grid.263518.b
230 schema:familyName Takeuchi
231 schema:givenName Yusuke
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727351117.01
233 rdf:type schema:Person
234 sg:person.0731477617.01 schema:affiliation grid-institutes:grid.263518.b
235 schema:familyName Matsuzaki
236 schema:givenName Satoshi
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731477617.01
238 rdf:type schema:Person
239 sg:person.0765147410.51 schema:affiliation grid-institutes:grid.255464.4
240 schema:familyName Masumoto
241 schema:givenName Junya
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765147410.51
243 rdf:type schema:Person
244 sg:pub.10.1007/s10067-016-3370-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008750519
245 https://doi.org/10.1007/s10067-016-3370-2
246 rdf:type schema:CreativeWork
247 sg:pub.10.1186/1546-0096-9-15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005348325
248 https://doi.org/10.1186/1546-0096-9-15
249 rdf:type schema:CreativeWork
250 sg:pub.10.1186/s12887-015-0424-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046549422
251 https://doi.org/10.1186/s12887-015-0424-6
252 rdf:type schema:CreativeWork
253 sg:pub.10.1203/01.pdr.0000352115.41382.65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052146328
254 https://doi.org/10.1203/01.pdr.0000352115.41382.65
255 rdf:type schema:CreativeWork
256 sg:pub.10.1203/pdr.0b013e31819ed68d schema:sameAs https://app.dimensions.ai/details/publication/pub.1046155604
257 https://doi.org/10.1203/pdr.0b013e31819ed68d
258 rdf:type schema:CreativeWork
259 grid-institutes:grid.255464.4 schema:alternateName Department of Pathology, Ehime University Proteo-Science Center and Graduate School of Medicine, Toon, Ehime, Japan
260 schema:name Department of Pathology, Ehime University Proteo-Science Center and Graduate School of Medicine, Toon, Ehime, Japan
261 rdf:type schema:Organization
262 grid-institutes:grid.263518.b schema:alternateName Department of Infection and Host Defense, Graduate School of Medicine, Shinshu University, Asahi 3-1-1, 390-8621, Matsumoto, Japan
263 Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan
264 schema:name Department of Infection and Host Defense, Graduate School of Medicine, Shinshu University, Asahi 3-1-1, 390-8621, Matsumoto, Japan
265 Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan
266 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...